Navigation Links
Seaside publishes research supporting disease-modifying potential of STX209 for fragile X syndrome
Date:9/19/2012

STX209 marking the first time a drug candidate has positively impacted a specific core symptom of fragile X. With continued success in ongoing clinical trials, I am hopeful that STX209 may be able to transform the treatment paradigm for fragile X syndrome which would confirm what I have believed all along that intellectual disability is not, as previously understood, an immutable condition."

FXS is the most common inherited cause of intellectual disability (mental retardation) and the most prevalent known cause of autism. FXS is caused by the mutation of a single gene known as FMR1. FMR1 codes for a protein called fragile X mental retardation protein (FMRP) that is necessary for normal brain development. Without FMRP, patients exhibit several changes in their brains that underlie the cognitive and behavioral deficits associated with FXS. These changes include: alterations of neuronal morphology and an imbalance between excitatory and inhibitory neurotransmission in the brain. In addition, changes in localized protein synthesis have been observed in mouse models of FXS.

In the paper entitled "Postnatal pharmacological activation of the GABA-B receptor has potential to be disease-modifying in fragile X syndrome," the researchers tested whether STX209 was effective in reversing the hallmark changes in the brains of mice lacking the Fmr1 gene. In vitro application of STX209 to the hippocampus of mice lacking Fmr1 reduced levels of localized protein synthesis to that of normal mice. Additionally, this treatment reduced a known functional consequence of increased protein synthesis, AMPA receptor internalization, to levels found in normal mice. Furthermore, in vivo administration of STX209 corrected alterations in neuronal morphology specific to Fmr1-deficient mice and FXS patients, but STX209 did not alter neuronal morphology in normal mice and STX209 also reduced protein translation in mice lacking Fmr1, but not in normal mice. Of note, the magnitu
'/>"/>

Contact: Kari Watson
kwatson@macbiocom.com
781-235-3060
MacDougall Biomedical Communications, Inc.
Source:Eurekalert

Page: 1 2 3 4

Related biology technology :

1. Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science
2. Nonprofit Consortium Publishes Review of Skullcap Adulteration
3. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
4. American Botanical Council Publishes a History of Adulteration
5. Stanford faculty awarded $2.2 million for innovative energy research
6. Electronics without current: Finnish team to research the future of nanoelectronics
7. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
8. Metabolic engineer synthesizes key breast milk ingredient, makes research possible
9. Penn researchers make first all-optical nanowire switch
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. All Market Research New Report @ Polyvinyl Chloride (PVC) Global Market to 2020 - Growth from Asia-Pacific Construction, Packaging and Electrical Sectors Continues to Drive Demand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 Histogen, Inc., ... the products of cells grown under simulated embryonic ... immunomodulatory treatment candidate for melanoma during the 2015 ... place May 6-9, 2015 in Atlanta, GA. , ... produce a soluble material with anti-oncologic properties, with ...
(Date:5/5/2015)... , May 5, 2015  Blueprint Medicines (NASDAQ: ... its initial public offering of 9,367,708 shares of ... $18.00 per share, including shares of common stock ... of their option to purchase additional shares. The ... Blueprint Medicines were approximately $168.6 million, before underwriting discounts ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 VetStem ... Science Animal Health, Jeffrey Schaffer, DVM, as Director ... over 15 years of experience in the veterinary ... great addition to our veterinarian lead organization”. ... explains. “Dr. Schaffer will be responsible for all ...
(Date:5/5/2015)... Israel , May 5, 2015  Tikcro ... Company was approved to continue trading on OTCQB  ... OTCQB Marketplace allows for a continuous ... broker-dealers. Investors can have real-time quotes and market ... The OTCQB Marketplace includes U.S. and ...
Breaking Biology Technology:Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2Blueprint Medicines Announces Closing of Initial Public Offering 2Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2
... Cardica, Inc.,(Nasdaq: CRDC ) and Cook Medical ... the development of vascular closure,devices. Cook Medical will pay ... product for the closure device product line. "We ... to the next device in our vascular closure product ...
... Spectral Diagnostics Inc.,(TSX:SDI) today announced the market launch ... product for sepsis, in Germany through,A. Menarini Diagnostics ... Sepsis is the third most common cause of ... treatment of severe sepsis consumes,about one third of ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a biopharmaceutical ... candidates for the treatment,of cancer and infectious diseases, ... officer, is scheduled to present at the 2007 ... at 8:00 a.m.,Eastern Time. The conference takes place ...
Cached Biology Technology:Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family 2Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family 3Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany 2ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference 2
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
(Date:4/1/2015)... BOSTON , April 1, 2015   Medisafe ... 1.5 million users across iOS and ... has begun integrating biofeedback into the platform to allow ... health outcomes. For the first time, patients will be ... missing a dose impacts important biometrics, such as glucose ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... examining how the hormone jasmonate works to protect plants ... repressor of the jasmonate signaling pathway makes its way ... hope the recently published discovery will eventually help farmers ... harmful chemicals., "This is a small piece of a ...
... observations have revealed the first direct evidence of smoke ... tarnishing the ice with soot and making it more ... American Geophysical Union meeting this week, an Ohio State ... Infrared Pathfinder Satellite Observation (CALIPSO) satellite, which captured smoke ...
... 5, 2012Researchers at St. Michael,s hospital have identified 29 ... spread of kidney cancer. The discovery will help physicians ... and provide those patients with more intensive treatment and ... the most treatment-resistant malignancies and patients have dismal prognosis," ...
Cached Biology News:Biologists unlocking the secrets of plant defenses, 1 piece at a time 2Fire and ice: Wildfires darkening Greenland snowpack, increasing melting 2
...
... Apoptosis is an evolutionarily conserved form ... cellular process. The central component of ... enzymes called caspases. These enzymes participate ... triggered in response to pro-apoptotic signals and ...
... System provides optimized reagents and protocols for ... genes by insertion of group II introns. ... group II introns and utilizes a simple ... II intron for specific insertion into the ...
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Biology Products: